Related Experiment Video

Updated: Aug 19, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Therapy considerations in drug-eluting stents

Jeffrey T Ellis, Deborah L Kilpatrick, Paul Consigny

    Critical Reviews in Therapeutic Drug Carrier Systems
    |February 18, 2005
    PubMed

    Insights

    Coronary artery disease affects millions, leading to significant mortality. However, drug-eluting stents have virtually eliminated restenosis, a common complication of cardiac interventions like stenting.

    Area of Science:

    • Cardiovascular Medicine
    • Interventional Cardiology
    • Biomedical Engineering

    Background:

    • Coronary artery disease (CAD) affects 12 million Americans, contributing to nearly 20% of US deaths.
    • Over 1.2 million cardiac catheterizations and 500,000 percutaneous coronary interventions (PCIs) are performed annually in the US.
    • Atherosclerosis, a progressive disease, causes significant coronary artery lesions and thrombotic events.

    Purpose of the Study:

    • To provide an overview of atherosclerosis, restenosis, and drug-eluting stents.
    • To explain the pathophysiology of coronary artery disease and its complications.
    • To highlight the impact of drug-eluting stents on restenosis rates.

    Main Methods:

    • Review of current literature on atherosclerosis and coronary interventions.
    • Analysis of the mechanisms underlying restenosis after PCI.
    • Examination of drug-eluting stent technology and its clinical outcomes.

    Main Results:

    • Atherosclerosis leads to hemodynamically significant coronary lesions.
    • Restenosis, the re-narrowing of arteries post-intervention, is a significant clinical challenge.
    • Drug-eluting stents have demonstrated near-complete elimination of restenosis.

    Conclusions:

    • Drug-eluting stents represent a major advancement in managing coronary artery disease.
    • The use of specific polymers and drugs in stents optimizes pharmacokinetic profiles to prevent restenosis.
    • These devices have transformed the treatment landscape for patients undergoing PCI.

    More Related Videos

    Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis08:26

    Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis

    Published on: January 21, 2020

    Related Concept Videos

    Cardiac Catheterization IV: Nursing Management01:26

    Cardiac Catheterization IV: Nursing Management

    Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
    Peripheral Artery Disease III: Interprofessional Care01:27

    Peripheral Artery Disease III: Interprofessional Care

    Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
    Imaging Studies for Cardiovascular System V: CT01:28

    Imaging Studies for Cardiovascular System V: CT

    Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
    Drug Delivery: Enteral Route01:18

    Drug Delivery: Enteral Route

    The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
    Drugs in...
    Peptic Ulcer Disease IV: Management01:26

    Peptic Ulcer Disease IV: Management

    Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
    The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
    Pharmacological management
    The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
    Angina IV: Management01:26

    Angina IV: Management

    IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...